Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
680.54B | 660.84B | 618.90B | 516.44B | 439.41B | 439.63B | Gross Profit |
234.96B | 228.72B | 195.64B | 171.02B | 146.69B | 145.27B | EBIT |
76.30B | 73.40B | 58.78B | 52.27B | 42.65B | 38.04B | EBITDA |
102.04B | 93.72B | 80.13B | 69.92B | 62.34B | 57.41B | Net Income Common Stockholders |
63.87B | 56.44B | 43.73B | 38.90B | 31.16B | 26.83B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
119.16B | 150.78B | 99.35B | 79.23B | 55.68B | 28.10B | Total Assets |
667.88B | 667.88B | 566.38B | 503.06B | 438.51B | 398.70B | Total Debt |
59.91B | 59.91B | 50.98B | 43.46B | 41.66B | 42.68B | Net Debt |
-59.25B | -59.25B | -48.36B | -35.77B | -14.02B | 14.58B | Total Liabilities |
169.62B | 169.62B | 149.41B | 139.15B | 124.99B | 121.15B | Stockholders Equity |
491.36B | 491.36B | 410.51B | 357.82B | 308.13B | 272.26B |
Cash Flow | Free Cash Flow | ||||
43.53B | 49.74B | 32.65B | 32.53B | 40.10B | 15.93B | Operating Cash Flow |
67.68B | 80.81B | 59.20B | 52.09B | 57.17B | 41.96B | Investing Cash Flow |
-41.14B | -42.99B | -26.62B | -16.11B | -16.89B | -28.78B | Financing Cash Flow |
-18.07B | -31.42B | -20.38B | -17.90B | -15.42B | -11.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $8.97B | 14.72 | 16.31% | 2.28% | -6.88% | -4.93% | |
74 Outperform | $8.93B | 21.88 | 12.17% | 1.11% | 1.77% | 4.28% | |
68 Neutral | $10.93B | 33.51 | 3.67% | 6.11% | -3.15% | -65.38% | |
67 Neutral | $19.25B | 24.65 | 14.73% | 2.42% | 0.40% | 10.89% | |
66 Neutral | $10.24B | 19.78 | 13.43% | 4.43% | 9.15% | -31.94% | |
65 Neutral | $8.86B | 14.97 | 4.70% | 203.29% | 3.53% | -2.11% | |
58 Neutral | $12.12B | 22.22 | -3.55% | 3.77% | 7.07% | -181.54% |